rups lifesciences private limited
Tender Performance & Track Record
Company Overview
Tender Performance
Data for 01 April 2024 to 14 September 2025
Total Bids / Contract Value
Qualified Bids / Q Rate
Total Wins / Win Value
Wins Rate / Q-W Rate
Detailed Performance Analysis
Tender Performance by Ministries
Name
Top Bid Competitors
Companies that frequently compete with you in the same tenders — ranked by their total win value.You applied for 9 bids — CL MICROMED PRIVATE LTD appeared in 1 of them.
RUPS LIFESCIENCES PRIVATE LIMITED
RUPS LIFESCIENCES PRIVATE LIMITED
Financial Details
Registered Office
A-4, GALI NO-1, YADAV ENCLAVE, VIKAS NAGARNA-NEW DELHI-Delhi-110059-India
Industry Classification
Manufacturing (Machinery & Equipments)
Company Type
Market Information
Transform Your Tender Process
Join thousands of businesses winning more tenders
Smart Alerts
Get AI-powered tender recommendations
Market Intel
Track competitor bidding patterns
Email Reports
Weekly detailed analytics reports
Download Hub
Export tender data in bulk format
Smart Tracking
Never miss important deadlines
& Much More...
Discover all premium features with your trial
"TendersAi transformed our bidding process. We've increased our win rate by 40% and saved countless hours."
Historical Performance
7-year trend analysis (2018-2025)
Company Overview (1 Apr 2018-31 Mar 2025))
Total Bids
41
Contract Value
₹23.43 Cr
L1 Bids
6
Recent Win Rate
40.0%
Performance Analytics
Rups Lifesciences Private Limited: Government Tender Analysis
Executive Summary
Rups Lifesciences Private Limited is an active participant in the Indian government procurement landscape, with a focus on healthcare-related tenders. Analysis of their tender performance data reveals several key insights into their strengths, weaknesses, opportunities, and threats.
As of March 2025, Rups Lifesciences has participated in 41 government tenders, achieving a 14.6% overall win rate. However, in the most recent fiscal year (FY 2024-25), their win rate surged to 40.0%, indicating a positive trend in their bidding strategy. This recent performance has translated to ₹1.14 crore in won contracts. While their qualification rate stands at 34.1% overall, improvements have been observed in recent periods.
TenderAI's financial health assessment assigns Rups Lifesciences a score of 27.0/100, categorizing their financial health as "Critical." The score is composed of factors such as bid efficiency (41.7), consistency (33.2), win rate (36.6) and contract value (13.6). This highlights areas needing strategic attention to improve overall financial performance.
In terms of market positioning, Rups Lifesciences faces stiff competition from established players. A detailed competitive analysis reveals key rivals such as GENIST TECHNOCRACY PRIVATE LIMITED and MEDEX INDIA PRIVATE LIMITED. Understanding their strategies and strengths is crucial for Rups Lifesciences to enhance its competitiveness. The company's strength lies in its lower bid, which can be leveraged by optimizing the supply chain. The company’s value proposition remains balanced in the market.
Rups Lifesciences has shown a strong focus on tenders from the Ministry of Health and Family Welfare, Health and Family Welfare Department Delhi, and other departments. Strengthening relationships with these key departments could lead to increased contract opportunities.